Sensus Healthcare, Inc. To Ring the Nasdaq Opening Bell

BOCA RATON, Fla., June 8, 2016 /PRNewswire/ -- Sensus Healthcare, Inc. (NASDAQ: SRTSU) ("Sensus" or the "Company"), a medical device company specializing in the treatment of non-melanoma skin cancers and other skin conditions, such as keloids, with superficial radiation therapy, today announced that CEO Joe Sardano will ring the Nasdaq opening bell on Thursday, June 9, 2016 to celebrate the Company's recent IPO.

"We could not think of a more fitting way to culminate months of hard work preparing Sensus to go public than to ring the Nasdaq opening bell alongside our partners and friends," said CEO Joe Sardano. "We believe that Sensus is at the forefront of a seismic shift in the way healthcare providers treat non-melanoma skin cancers and keloids. Our IPO not only provides us with the capital to expand operations but also gives us increased visibility among members of the financial community and general public at large, who view Nasdaq as the place to be for dynamic, high growth public companies."

Sardano will ring the opening bell at 9:30 a.m. ET and will be joined by Sensus management, board members and medical advisors. The event will be broadcast live from the Nasdaq MarketSite in New York, starting at 9:15 a.m. ET and viewable online at https://new.livestream.com/nasdaq/live

About Sensus

Sensus Healthcare, Inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (SRT), which is a result of over a decade of dedicated research and development activities. Sensus has successfully incorporated the SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, the SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://www.sensushealthcare.com.

Investor Relations Contacts:

Jeffrey Goldberger / Allison Soss
KCSA Strategic Communications
Phone: 212-896-1249 / 212-896-1267
Email: [email protected] / [email protected] 

SOURCE Sensus Healthcare

Related Links

http://www.sensushealthcare.com